Here’s Why Qiagen Skyrocketed Over 43% in November
Shares of Qiagen (NYSE: QGEN) jumped 43.6% in November, according to data provided by S&P Global Market Intelligence, after the maker of scientific and diagnostic tests said that it was considering a potential sale of the company.
Bloomberg initially reported that Thermo Fisher Scientific (NYSE: TMO) was looking to acquire Qiagen, although it cited unnamed sources, and the companies weren't willing to confirm that they were in talks.
And then a few days later, Qiagen acknowledged that it had received several "indications of interest" to be acquired and was exploring strategic alternatives.
Source Fool.com